| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Dutch Growth Research Foundation (R.F.A.d.L.v.W., A.C.S.H.-K.), 3016 AH Rotterdam, The Netherlands; Erasmus University Medical Center Rotterdam/Sophia Childrens Hospital, Department of Pediatrics, Subdivisions of Endocrinology (R.F.A.d.L.v.W., A.C.S.H.-K.) and Intensive Care (K.F.M.J., S.v.d.B.), 3015 GJ Rotterdam, The Netherlands; Radboud University Nijmegen Medical Center (B.J.O.), Department of Pediatrics, Subdivision of Endocrinology, 6525 GA Nijmegen, The Netherlands; Erasmus University Medical Center Rotterdam, Department of Internal Medicine (F.H.d.J.), Laboratory of Endocrinology, 3015 GE Rotterdam, The Netherlands; Radboud University Nijmegen Medical Center (C.G.J.S.), Department of Chemical Endocrinology, 6525 GA Nijmegen, The Netherlands; and Sleep Center SEIN (A.W.d.W.), 8025 BV Zwolle, The Netherlands
Address all correspondence and requests for reprints to: Roderick de Lind van Wijngaarden, Clinical Research Fellow, Dutch Growth Research Foundation, and Erasmus University Medical Center/Sophia Childrens Hospital, Westzeedijk 106, 3016 AH Rotterdam, The Netherlands. E-mail: r.delindvanwijngaarden{at}erasmusmc.nl.
Background: The annual death rate of patients with Prader-Willi syndrome (PWS) is high (3%). Many deaths of children are sudden and unexplained. Sleep apneas have been suggested to play a role in sudden deaths. Recently, we discovered that 60% of patients with PWS suffer from central adrenal insufficiency (CAI) during stress.
Objective: The aim was to study the relationship between CAI and sleep-related breathing disorders.
Design: In 20 children with PWS who underwent a metyrapone test (30 mg/kg at 2330 h), sleep-related breathing was evaluated by polysomnography before the metyrapone test. In addition, we recorded sleep-related breathing in 10 children with PWS during their metyrapone test. CAI was diagnosed when ACTH levels during the metyrapone test were below 33 pmol/liter at 0730 h. All tests were performed during healthy condition.
Setting: The study was conducted in a pediatric intensive care unit and specialized sleep center.
Results: Median (interquartile range) age was 8.4 yr (6.5–10.2). After metyrapone administration, median (interquartile range) central apnea index (number/hour) increased significantly from 2.2 (0.4–4.7) to 5.2 (1.5–7.9) (P = 0.007). The increase tended to be higher in children with CAI [2.8 (2.0–3.9) vs. 1.0 (–0.2 to 2.6); P = 0.09]. During polysomnography before the metyrapone test, sleep-related breathing was worse in children with CAI, who had a significantly higher central apnea index and tended to have a lower minimum oxygen saturation compared to those without CAI (P = 0.03 and P = 0.07).
Conclusions: In children with PWS, the central apnea index increased significantly after metyrapone administration, particularly in those with CAI during stress. In addition, children with CAI had a higher central apnea index compared to those without several months before the metyrapone test.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |